Involvement of redox signalling in tumour cell dormancy and metastasis.
Autor: | Puente-Cobacho B; Department of Genomic Medicine, GENYO, Centre for Genomics and Oncology, Pfizer-University of Granada and Andalusian Regional Government, PTS, Granada, Spain., Varela-López A; Department of Physiology, Institute of Nutrition and Food Technology 'José Mataix Verdú', Biomedical Research Center, University of Granada, Granada, Spain., Quiles JL; Department of Physiology, Institute of Nutrition and Food Technology 'José Mataix Verdú', Biomedical Research Center, University of Granada, Granada, Spain., Vera-Ramirez L; Department of Genomic Medicine, GENYO, Centre for Genomics and Oncology, Pfizer-University of Granada and Andalusian Regional Government, PTS, Granada, Spain. lvera@ugr.es.; Department of Physiology, Institute of Nutrition and Food Technology 'José Mataix Verdú', Biomedical Research Center, University of Granada, Granada, Spain. lvera@ugr.es. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cancer metastasis reviews [Cancer Metastasis Rev] 2023 Mar; Vol. 42 (1), pp. 49-85. Date of Electronic Publication: 2023 Jan 26. |
DOI: | 10.1007/s10555-022-10077-9 |
Abstrakt: | Decades of research on oncogene-driven carcinogenesis and gene-expression regulatory networks only started to unveil the complexity of tumour cellular and molecular biology. This knowledge has been successfully implemented in the clinical practice to treat primary tumours. In contrast, much less progress has been made in the development of new therapies against metastasis, which are the main cause of cancer-related deaths. More recently, the role of epigenetic and microenviromental factors has been shown to play a key role in tumour progression. Free radicals are known to communicate the intracellular and extracellular compartments, acting as second messengers and exerting a decisive modulatory effect on tumour cell signalling. Depending on the cellular and molecular context, as well as the intracellular concentration of free radicals and the activation status of the antioxidant system of the cell, the signalling equilibrium can be tilted either towards tumour cell survival and progression or cell death. In this regard, recent advances in tumour cell biology and metastasis indicate that redox signalling is at the base of many cell-intrinsic and microenvironmental mechanisms that control disseminated tumour cell fate and metastasis. In this manuscript, we will review the current knowledge about redox signalling along the different phases of the metastatic cascade, including tumour cell dormancy, making emphasis on metabolism and the establishment of supportive microenvironmental connections, from a redox perspective. (© 2023. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |